OverweightNCT07558421
The Effects of Exercise Snacks on Endothelial Function and Body Composition in Overweight Individuals
A study testing Short-term stair climbing exercise snack group, Long-duration stair climbing exercise snack group and Moderate-intensity continuous exercise（MICT） in people with Overweight and Obesity, run by Weifang Medical University.
Trial summary
This randomized controlled trial investigates the effects of two types of stair-climbing exercise snacks versus moderate-intensity continuous training on vascular health, body composition, and blood lipids in overweight or obese adults. Participants will be assigned to one of four groups for 6-8 weeks. Read more about this study
- Who is it for?
- Ages 18 to 35 years
- Conditions the study is for
- Overweight, Obesity
- What is being tested?
- Short-term stair climbing exercise snack group, Long-duration stair climbing exercise snack group and Moderate-intensity continuous exercise（MICT）
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 16 Apr 2026to 20 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age: 18-35 years old (male, female);
- Clear consciousness, stable vital signs;
- Able to understand and follow simple instructions;
- No regular exercise for at least 3 months;
- BMI ≥ 24 kg/m2.
Who cannot join
- There are other serious diseases, such as tumors;
- There are other neurological diseases;
- There are serious diseases that simultaneously affect the heart, liver, kidneys, endocrine system or hematopoietic system;
- There is a history of alcohol or drug abuse;
- Participated in other clinical trials that might affect the results of this study;
- There are other neurological or musculoskeletal diseases, with pain worsening with exercise;
Show all 13Show fewer
- It is forbidden to engage in physical training.
- Within the past 3 months, there have been acute cardiovascular events such as acute myocardial infarction,unstable angina pectoris, severe arrhythmia, acute heart failure, etc.；
- Uncontrolled hypertension；
- Severe pulmonary diseases, such as uncontrolled asthma, acute exacerbation of chronic obstructive pulmonary disease, interstitial lung disease with significant exercise limitation；
- Severe joint and bone diseases, acute soft tissue injuries, fractures that have not healed, etc., making it impossible to complete the prescribed exercise load；
- Presence of bleeding tendencies, coagulation dysfunction, or within the past 1 month, there has been major bleeding or a history of surgery；
- The investigator judges that there are any other situations that may affect the safety of the subjects or the results of the trial.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
This randomized controlled trial investigates the effects of two types of stair-climbing exercise snacks versus moderate-intensity continuous training on vascular health, body composition, and blood lipids in overweight or obese adults. Participants will be assigned to one of four groups for 6-8 weeks. The control group receives no exercise intervention. Primary outcomes include endothelial function (ultrasound), body composition (InBody), and lipid profile (blood test).
Read the detailed description
This is a parallel group randomized controlled trial, with the study subjects being overweight or obese adults (with a body mass index of ≥ 24 kg/m²). Participants will be recruited from universities and randomly assigned to one of the following four groups:
Short-term stair climbing exercise group Participants climbed the stairs 4 to 5 times a day, each time ascending 5 floors (approximately 1 minute each time). There was at least a 1-hour interval between each exercise session, and the exercises were carried out during daily activities. They exercised 3 to 5 times a week for 6 to 8 weeks.
Long-term stair climbing nutrition supplementation group The participants also conducted 4 to 5 stair climbing training sessions every day. Each training session consisted of 3 sets of climbing 5 floors (the total climbing height for each training session was 15 floors), with a rest period of no more than 1 minute between each set. The interval between two training sessions was no less than 1 hour. They exercised 3 to 5 times a week for 6 to 8 weeks.
Moderate-intensity continuous training group (MICT) Participants engaged in 30-minute moderate-intensity running (including warm-up and cool-down activities) each time, 3 to 5 times a week, for 6 to 8 weeks.
Control group Participants maintained their daily activities and did not receive any exercise intervention measures.
Result measurement indicators:
Vascular health: Assessing endothelial function through ultrasound measurement of flow-mediated vascular dilation (FMD).
Body composition: Measured using the InBody body bioelectrical impedance analyzer (including muscle mass, fat mass and body fat percentage).
Blood lipid test: Collect fasting blood samples and measure low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TG), and total cholesterol (TC).
Measurement time points: Measurements were conducted at the baseline (at the beginning of the study), 3-4 weeks (during the intervention period), and 8 weeks (after the intervention ended).
This research protocol has been approved by the Institutional Review Board of Shandong Second Medical University. All participants are required to sign a written informed consent form.
- Conditions
- Overweight, Obesity
- Being tested
- Short-term stair climbing exercise snack group, Long-duration stair climbing exercise snack group, Moderate-intensity continuous exercise（MICT）
- Medical subject headings
- Overweight, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Short-term stair climbing exercise snack groupBehavioural
Adopt a fragmented approach, climbing stairs 4-5 times a day, each time climbing 5 floors (approximately 1 minute per session), with at least 1 hour of interval between each session, and spread throughout the daily activity periods. Exercise 3-5 days per week for a total of 6-8 weeks.
Long-duration stair climbing exercise snack groupBehavioural
On the basis of climbing stairs 4 to 5 times a day, increase the single exercise volume: complete 2 or 3 sets of climbing 5 floors of stairs each time (that is, the total number of floors climbed each time is 10 or 15), with no more than 1 minute of rest between sets. The intervals between each exercise should be at least 1 hour. Exercise 3 to 5 days a week, for a total of 6 to 8 weeks of intervention.
Moderate-intensity continuous exercise（MICT）Behavioural
Exercise 3 to 5 days per week for a total of 6 to 8 weeks. Perform 30 minutes of moderate-intensity running training every day.
| Study group | Role | What they receive |
|---|---|---|
| Short-term stair climbing exercise snack group | Experimental | Participants perform short climbs of the stairs 4 to 5 times a day. Each climb involves going up 5 floors (approximately 1 minute), and there is a minimum interval of at least 1 hour between each climb. Receives: Behavioral: Short-term stair climbing exercise snack group |
| Long-duration stair climbing exercise snack group | Experimental | Participants climbed the ladder 4 to 5 times a day. Each climb consisted of 2 to 3 sets (each set involved climbing 5 floors, with a rest period of no more than 1 minute between sets), and the total number of floors climbed in a single session was 10 or 15. Receives: Behavioral: Long-duration stair climbing exercise snack group |
| Moderate-intensity continuous exercise | Experimental | The participants engaged in moderate-intensity running training for 3 to 5 days per week, with each session lasting for 30 minutes. Receives: Behavioral: Moderate-intensity continuous exercise（MICT） |
| control group | No intervention | The participants did not undergo any form of exercise intervention and maintained their usual activity patterns. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Flow-mediated dilation (FMD, relative percentage)
Flow-mediated dilation expressed as a percentage of the baseline brachial artery diameter.Unit of Measure: %
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body fat mass
Body fat mass measured by bioelectrical impedance analysis (InBody device). Unit of Measure: kg
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Time to peak dilation
Time required to reach maximal dilation after cuff deflation.Unit of Measure: seconds
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Basal brachial artery diameter
Baseline diameter of the brachial artery before cuff inflation.Unit of Measure: mm
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Peak brachial artery diameter
Maximal diameter of the brachial artery after reactive hyperemia.Unit of Measure: mm
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Absolute flow-mediated dilation (FMDabs)
Absolute change in diameter, calculated as peak diameter minus basal diameter.Unit of Measure: mm
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Standardized FMD
Flow-mediated dilation adjusted for relevant covariates (e.g., shear stress, baseline diameter) according to standard protocols.Unit of Measure: %
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body weight
Body weight measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body fat percentage
Body fat percentage measured by bioelectrical impedance analysis (InBody device).Unit of Measure: %
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body mass index (BMI)
Body mass index calculated from weight and height measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg/m²
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Basal metabolic rate (BMR)
Basal metabolic rate estimated by bioelectrical impedance analysis (InBody device).Unit of Measure: kcal
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Waist circumference
Waist circumference measured by bioelectrical impedance analysis (InBody device).Unit of Measure: cm
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Visceral fat area
Visceral fat area measured by bioelectrical impedance analysis (InBody device). Unit of Measure: cm²
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Skeletal muscle mass
Skeletal muscle mass measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Secondary outcomes (8)
Systolic blood pressure (SBP)
Systolic blood pressure measured using an electronic sphygmomanometer.Unit of Measure: mmHg
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Serum high-density lipoprotein (HDL) cholesterol concentration
Fasting serum HDL cholesterol concentration measured from blood samples. Unit of Measure: mmol/L
Measured: Measured at baseline and post-intervention (after 6-8 weeks).
Diastolic blood pressure (DBP)
Diastolic blood pressure measured using an electronic sphygmomanometer. Unit of Measure: mmHg
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Heart rate
Heart rate measured using an electronic sphygmomanometer.Unit of Measure: bpm (beats per minute)
Measured: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Serum low-density lipoprotein (LDL) cholesterol concentration
Fasting serum LDL cholesterol concentration measured from blood samples. Unit of Measure: mmol/L
Measured: Measured at baseline and post-intervention (after 6-8 weeks).
Serum total cholesterol concentration
Fasting serum total cholesterol concentration measured from blood samples. Unit of Measure: mmol/L
Measured: Measured at baseline and post-intervention (after 6-8 weeks).
HDL/LDL cholesterol ratio
Ratio of serum HDL cholesterol to LDL cholesterol calculated from fasting blood samples.Unit of Measure: ratio (dimensionless)
Measured: Measured at baseline and post-intervention (after 6-8 weeks).
Serum triglyceride concentration
Fasting serum triglyceride concentration measured from blood samples.Unit of Measure: mmol/L
Measured: Measured at baseline and post-intervention (after 6-8 weeks).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Apr 2026
- Study start16 Apr 2026 (estimated)
- Primary completion16 Jun 2026 (estimated)
- Study completion20 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OverweightStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Weifang Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- YANXIA WANG, PhD, Principal investigator, Weifang Medical University(Renamed Shandong Second Medical University)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07558421
- Sponsor's protocol ID
- 2026YX160
- Status last verified
- Apr 2026
- First submitted
- 13 Apr 2026
- Last updated
- 30 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Exercise Snacks on Endothelial Function and Body Composition in Overweight Individuals
- ClinicalTrials.gov ID
- NCT07558421
- Acronym / sponsor ID
- 2026YX160
- Conditions
- Overweight, Obesity
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Weifang Medical UniversityUniversity, hospital or other
- Study start
- 16 Apr 2026 (estimated)
- Primary completion
- 16 Jun 2026 (estimated)
- Study completion
- 20 Jul 2026 (estimated)
- First posted
- 30 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial investigates the effects of two types of stair-climbing exercise snacks versus moderate-intensity continuous training on vascular health, body composition, and blood lipids in overweight or obese adults. Participants will be assigned to one of four groups for 6-8 weeks. The control group receives no exercise intervention. Primary outcomes include endothelial function (ultrasound), body composition (InBody), and lipid profile (blood test).
Detailed description
This is a parallel group randomized controlled trial, with the study subjects being overweight or obese adults (with a body mass index of ≥ 24 kg/m²). Participants will be recruited from universities and randomly assigned to one of the following four groups:
Short-term stair climbing exercise group Participants climbed the stairs 4 to 5 times a day, each time ascending 5 floors (approximately 1 minute each time). There was at least a 1-hour interval between each exercise session, and the exercises were carried out during daily activities. They exercised 3 to 5 times a week for 6 to 8 weeks.
Long-term stair climbing nutrition supplementation group The participants also conducted 4 to 5 stair climbing training sessions every day. Each training session consisted of 3 sets of climbing 5 floors (the total climbing height for each training session was 15 floors), with a rest period of no more than 1 minute between each set. The interval between two training sessions was no less than 1 hour. They exercised 3 to 5 times a week for 6 to 8 weeks.
Moderate-intensity continuous training group (MICT) Participants engaged in 30-minute moderate-intensity running (including warm-up and cool-down activities) each time, 3 to 5 times a week, for 6 to 8 weeks.
Control group Participants maintained their daily activities and did not receive any exercise intervention measures.
Result measurement indicators:
Vascular health: Assessing endothelial function through ultrasound measurement of flow-mediated vascular dilation (FMD).
Body composition: Measured using the InBody body bioelectrical impedance analyzer (including muscle mass, fat mass and body fat percentage).
Blood lipid test: Collect fasting blood samples and measure low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TG), and total cholesterol (TC).
Measurement time points: Measurements were conducted at the baseline (at the beginning of the study), 3-4 weeks (during the intervention period), and 8 weeks (after the intervention ended).
This research protocol has been approved by the Institutional Review Board of Shandong Second Medical University. All participants are required to sign a written informed consent form.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Short-term stair climbing exercise snack group | Experimental | Behavioral: Short-term stair climbing exercise snack groupParticipants perform short climbs of the stairs 4 to 5 times a day. Each climb involves going up 5 floors (approximately 1 minute), and there is a minimum interval of at least 1 hour between each climb. |
| Long-duration stair climbing exercise snack group | Experimental | Behavioral: Long-duration stair climbing exercise snack groupParticipants climbed the ladder 4 to 5 times a day. Each climb consisted of 2 to 3 sets (each set involved climbing 5 floors, with a rest period of no more than 1 minute between sets), and the total number of floors climbed in a single session was 10 or 15. |
| Moderate-intensity continuous exercise | Experimental | Behavioral: Moderate-intensity continuous exercise（MICT）The participants engaged in moderate-intensity running training for 3 to 5 days per week, with each session lasting for 30 minutes. |
| control group | No intervention | –The participants did not undergo any form of exercise intervention and maintained their usual activity patterns. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Age: 18-35 years old (male, female);
- Clear consciousness, stable vital signs;
- Able to understand and follow simple instructions;
- No regular exercise for at least 3 months;
- BMI ≥ 24 kg/m2.
Key exclusion criteria (13 listed)
- There are other serious diseases, such as tumors;
- There are other neurological diseases;
- There are serious diseases that simultaneously affect the heart, liver, kidneys, endocrine system or hematopoietic system;
- There is a history of alcohol or drug abuse;
- Participated in other clinical trials that might affect the results of this study;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Short-term stair climbing exercise snack groupAdopt a fragmented approach, climbing stairs 4-5 times a day, each time climbing 5 floors (approximately 1 minute per session), with at least 1 hour of interval between each session, and spread throughout the daily activity periods. Exercise 3-5 days per week for a total of 6-8 weeks. | Behavioural | Short-term stair climbing exercise snack group |
| Long-duration stair climbing exercise snack groupOn the basis of climbing stairs 4 to 5 times a day, increase the single exercise volume: complete 2 or 3 sets of climbing 5 floors of stairs each time (that is, the total number of floors climbed each time is 10 or 15), with no more than 1 minute of rest between sets. The intervals between each exercise should be at least 1 hour. Exercise 3 to 5 days a week, for a total of 6 to 8 weeks of intervention. | Behavioural | Long-duration stair climbing exercise snack group |
| Moderate-intensity continuous exercise（MICT）Exercise 3 to 5 days per week for a total of 6 to 8 weeks. Perform 30 minutes of moderate-intensity running training every day. | Behavioural | Moderate-intensity continuous exercise |
Primary outcome
Flow-mediated dilation (FMD, relative percentage)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Flow-mediated dilation expressed as a percentage of the baseline brachial artery diameter.Unit of Measure: %
Body fat mass
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body fat mass measured by bioelectrical impedance analysis (InBody device). Unit of Measure: kg
Time to peak dilation
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Time required to reach maximal dilation after cuff deflation.Unit of Measure: seconds
Basal brachial artery diameter
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Baseline diameter of the brachial artery before cuff inflation.Unit of Measure: mm
Peak brachial artery diameter
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Maximal diameter of the brachial artery after reactive hyperemia.Unit of Measure: mm
Absolute flow-mediated dilation (FMDabs)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Absolute change in diameter, calculated as peak diameter minus basal diameter.Unit of Measure: mm
Standardized FMD
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Flow-mediated dilation adjusted for relevant covariates (e.g., shear stress, baseline diameter) according to standard protocols.Unit of Measure: %
Body weight
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body weight measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg
Body fat percentage
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body fat percentage measured by bioelectrical impedance analysis (InBody device).Unit of Measure: %
Body mass index (BMI)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Body mass index calculated from weight and height measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg/m²
Basal metabolic rate (BMR)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Basal metabolic rate estimated by bioelectrical impedance analysis (InBody device).Unit of Measure: kcal
Waist circumference
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Waist circumference measured by bioelectrical impedance analysis (InBody device).Unit of Measure: cm
Visceral fat area
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Visceral fat area measured by bioelectrical impedance analysis (InBody device). Unit of Measure: cm²
Skeletal muscle mass
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Skeletal muscle mass measured by bioelectrical impedance analysis (InBody device).Unit of Measure: kg
8 secondary outcomes
Systolic blood pressure (SBP)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Serum high-density lipoprotein (HDL) cholesterol concentration
Time frame: Measured at baseline and post-intervention (after 6-8 weeks).
Diastolic blood pressure (DBP)
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Heart rate
Time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).
Serum low-density lipoprotein (LDL) cholesterol concentration
Time frame: Measured at baseline and post-intervention (after 6-8 weeks).
Serum total cholesterol concentration
Time frame: Measured at baseline and post-intervention (after 6-8 weeks).
HDL/LDL cholesterol ratio
Time frame: Measured at baseline and post-intervention (after 6-8 weeks).
Serum triglyceride concentration
Time frame: Measured at baseline and post-intervention (after 6-8 weeks).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2026.
- Individual participant dataSharing planned: No
Related trials for Overweight
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Recruiting
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Overweight, Obesity
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Not yet recruitingObservational study
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Pediatric Obesity, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
YANXIA WANG, PhD principal investigator
Weifang Medical University(Renamed Shandong Second Medical University)
Questions about this trial
What is this clinical trial studying?
A study testing Short-term stair climbing exercise snack group, Long-duration stair climbing exercise snack group and Moderate-intensity continuous exercise（MICT） in people with Overweight and Obesity, run by Weifang Medical University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact XINCHEN ZHANG (+8615094866869, zhangxinchen2001@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Flow-mediated dilation (FMD, relative percentage) (time frame: Measured at baseline, mid-intervention (approximately 3-4 weeks), and post-intervention (after 6-8 weeks).). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.